R&D
Research achievement
Domestic Patent Status
| Classification | Invention title | Registration number (application number) |
Registration date (Application date) |
|---|---|---|---|
| Application | Composition for self-emulsifying drug delivery system containing CoQ 10. | 10-2016-0045143 | Apr. 12, 2016 |
| Composition for anticoagulant comprising wild parsley extract and anti-thrombotic agent. | 10-2017-0135472 | Oct. 18, 2017 | |
| Composition for prevention or treatment of dementia, comprising compound K and decursinol. | 10-2018-0115748 | Apr. 08, 2018 | |
| Registration | Macrolide antibiotics manufacturing method using novel intermediate agent. | 10-0317907 | Dec. 05, 2001 |
| Tablet, formed by composition of Olanzapine and composition of extended release pallets containing Olanzapine. | 10-1244627 | Mar. 12, 2013 | |
| Pharmaceutical composition containing ginsenoside sapogenin as an active ingredient. | 10-1889866 | Aug. 13, 2018 | |
| Exclusive patent right | Composition for prevention or treatment inflammatory disease containing cell adhesion inhibitory substances isolated from black pepper as active ingredients. | 10-0954866 | Apr. 19, 2010 |
| Composition for prevention and treatment of inflammatory disease containing cell adhesion inhibitory substances isolated from piper longum as active ingredients. | 10-0954865 | Apr. 19, 2019 | |
| Composition for prevention or treatment of STAT 3 mediated disease containing extracts or fractions of common sage as an active ingredients. | 10-1487935 | Jan. 23, 2015 | |
| Composition for prevention or treatment of IL-6 mediated disease containing extracts of fractions of portulaca extract as active ingredients. | 10-1577792 | Dec. 09, 2015 | |
| Pharmaceutical composition for prevention or treatment of STAT 3 mediated disease containing sesquiterpene compounds as an active ingredient, and their use. | 10-1741017 | May 23, 2017 | |
| Pharmaceutical composition for prevention or treatment of STAT 3 mediated disease containing ursolic acid acetate as an active ingredient, and their use. | 10-1777770 | Sep. 06, 2017 | |
| Pharmaceutical composition for prevention or treatment of STAT 3 mediated disease containing pterulone compounds as an active ingredient. | 10-1924737 | Nov. 27, 2018 | |
| Oral administration agent for improvement of sexual function. | 10-2017-0169362 | Dec. 12, 2017 | |
| Ordinary patent right | Oral administration agent for increasing sperm count. | 10-1144715 | May 03, 2012 |
| Composition for enhancing exercise performance. | 10-1557410 | Sep. 25, 2015 | |
| Method of manufacturing injectable and eye drop solution forming homogeneous solution by solubilizing poorly soluble pharmacologically active ingredients. | 10-1717672 | Mar. 13, 2017 | |
| Method of preparing homogeneous solution formation of poorly soluble pharmacologically active ingredient using ethanol and alkaline amino acid. | 10-1728799 | Apr. 14, 2017 |
